UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of April 2026

Commission File Number: 001-42213

WeRide Inc.

21st Floor, Tower A, Guanzhou Life Science Innovation Center

No. 51, Luoxuan Road, Guangzhou International Biotech Island

Guangzhou 510005

People’s Republic of China

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

EXPLANATORY NOTE

We submitted a monthly return form dated April 9, 2026 in relation to the movements in our authorized share capital and issued shares in March 2026 to The Stock Exchange of Hong Kong Limited. For details, please refer to the exhibit to this current report on Form 6-K.

EXHIBIT INDEX

Exhibit No.		Description
99.1		~~Monthly~~Announcement—Grant ~~Return~~of ~~for~~Restricted ~~Equity~~Share ~~Issuer~~Units onPursuant ~~Movements~~to in2026 ~~Securities~~Share Plan

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	WeRide Inc.

	By:	/s/ Jennifer Li
	Name:	Jennifer Li
	Title:	Chief Financial Officer

Date: April 910, 2026

Filing Compare · WeRide Inc.